Biotechnology

Amgen 2013 Revenue Forecast Tops Street Estimates

Novozymes Says Efficiency Boost to Keep Margins High

Life Tech Exploring Potential Sale

Amgen to Build Biotech Manufacturing Plant in Singapore

DSM Announces License Agreement with Amgen

Amgen Trims 2012 EPS Estimate, Citing R&D Tax Credit Delay

Shire Adds to Genetic Disorder Drugs with U.S. Deal

Sartorius, Lonza Announce Collboration on Cell Culture Media

Hookipa Appoints New Members to Management Team

Actelion Sticks to Forecast for Return to Growth from 2014

Celgene Issues 2013, Long-term Forecasts

Genetically Modified Food Labeling Measure to Qualify for Washington State Ballot

Italy's Philogen Signs Drug License Deal with Pfizer

Entering the Age of the $1 Million Medicine

Roche, PSS Team Up to Automate Gene Sample Preparation

U.S. Court Approves Amgen's $762 Million Payment in Drug Case

Amgen Pleads Guilty to Misbranding Charges, Will Pay $762 Million

Russian Billionaire Invests in US Genetics Company 23andMe

Amgen Buys Icelandic Gene Pioneer Decode for $415 Million

U.S. Supreme Court to Decide if Human Genes Patentable

Prof. Stefan Buchholz to head Evonik's R&D group Creavis

German Research Points Way to Faster Flu Vaccines

Sanofi Lets Genzyme's Biotech Culture Call the Shots

GeneQuine Biotherapeutics Closes Seed Financing

Applikon, Thermo Fisher Sign Bilateral Supply Agreement

Dendreon Posts Better-Than-Expected Q3 Results

Europe Approves High-Price Gene Therapy

Vertex Posts Q3 Loss as Hepatitis Drug Sales Plunge

Nomad Bioscience, Bayer Cropscience to Enter into Strategic Partnership

Biogen Q3 Profit Rises

Celgene Profit Beats Forecasts as Revlimid Delivers

Amgen Q3 Profits Up

Fujifilm Diosynth Biotechnologies, Piramal Announce Strategic Alliance

ThromboGenics Says Main Drug Cleared for U.S. Launch

Focus on New Actelion Drug as Tracleer Sales Slip

103 more articles

Top-Feature

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Predictive Simulation in Pharma Production

CHEManager International c/o Wiley-VCH GmbH

Event Sponsorship: Next Generation Batteries and Hydrogen

Free Virtual Event

Batteries and Hydrogen: Competitors or Partners?

CHEManager Spotlight

Batteries and Hydrogen: Competitors or Partners?

17 September 2026 | Reserve your spot to learn where solid-state batteries and green hydrogen are headed—and how leading teams are turning them into scalable energy storage solutions.

Numaferm GmbH

Farmindustria

CzechInvest

Bio4Business

Federchimica

BioCampus Straubing

WuXi AppTec

Millipore Corporation

Dechema e.V.

Germany Trade & Invest

Tufts University

GETEC Group

Evonik Industries AG

Groupe Novasep

Sartorius AG

Arthur D. Little

Beckman Coulter, Inc.

Managm. Consult. Chemicals

Hamilton AG

Novozymes Biopharma UK Ltd.

AstraZeneca

Primogene GmbH

GEA Liquid Processing

Thomson Reuters

Alira Health S.r.l.

European Circular Bioeconomy Fund (ECBF)

Jennewein Biotechnologie GmbH

Olon S.p.A.

International Sustainable Chemistry Collaborative Centre ISC3

PhytoAR Biotechnologie GmbH

Simon-Kucher & Partners Strategy & Marketing Consultants GmbH

AbbVie Inc.

Bio Consortia

Dottikon Exclusive Synthesis AG

Jan Ramakers Fine Chemical

Miebach Consulting GmbH

Scienceindustries - Wirtschaftsverband Chemie Pharma Life Sciences

ACIB Austrian Centre of Industrial Biotechnology